TORLEY HELEN (PRESIDENT AND CEO) sold 1.3% of their position (10K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $635.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/7/2026ACC: 0001159036-26-000048
DirectorOfficer· PRESIDENT AND CEO
Since Mar 2026
-10K
Net shares
Net seller
$635.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10K
Price / share
$12.07
Trade value
$120.70K
% of position
1.3%
4/6/2026
767.78K→777.78K
Common Stock
Direct
Shares
−5.90K
Price / share
$63.14
Trade value
$372.52K
% of position
0.8%
4/6/2026
777.78K→771.88K
Common Stock
Direct
Shares
−4.10K
Price / share
$64.02
Trade value
$262.46K
% of position
0.5%
4/6/2026
771.88K→767.78K
Total
Net shares
+0.00
Net value
-$514.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | M · Option Exercise | +10K | $12.07 | $120.70K | 1.3% | 767.78K | 777.78K |
| Common Stock Direct | 4/6/2026 | S · Sale | −5.90K | $63.14 | $372.52K | 0.8% | 777.78K | 771.88K |
| Common Stock Direct | 4/6/2026 | S · Sale | −4.10K | $64.02 | $262.46K | 0.5% | 771.88K | 767.78K |
| Total | +0.00 | -$514.28K | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
12.07
Held after
101.92K
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock10K shares | 4/6/2026 | M · Option Exercise | −10K | 12.07 | — | 101.92K |